Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

P53 mediates phospholipid headgroup scavenging [RNA-seq]

ABSTRACT: A growing number of studies have shown that p53 modulates metabolic pathways to support diverse biological functions. Given that p53 is most widely known to act as a transcriptional activator, this raises the possibility that p53 transcriptional activity governs metabolic reprogramming. Here, we performed targeted metabolomics and lipidomic analysis which revealed an increase in the de novo biosynthesis of phosphatidylethanolamine (PE) upon p53 activation. Elevated levels of phosphoethanolamine (PEtn), the PE headgroup, in p53 active cells are sustained through PE headgroup recycling, which is partially mediated through the transcriptional activation of autophagy by p53. Disruption of phospholipid headgroup recycling through genetic perturbation of the CDP-ethanolamine pathway results in defects in cell-state specific perturbations in growth and gene expression. Notably, we observe restructuring of endoplasmic reticulum (ER)-mitochondria contacts in cells where headgroup recycling was abrogated, likely an attempt to maintain lipid homeostasis, and this reorganization is reversed when flux through the CDP-Etn pathway is restored. Together, these results suggest that lipid recycling to be an additional tool in the p53 arsenal supporting cellular fitness.

ORGANISM(S): Mus musculus

PROVIDER: GSE268723 | GEO | 2025/11/17

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

p53 mediates phospholipid headgroup scavenging [ChIP-seq]

Project description:A growing number of studies have shown that p53 modulates metabolic pathways to support diverse biological functions. Given that p53 is most widely known to act as a transcriptional activator, this raises the possibility that p53 transcriptional activity governs metabolic reprogramming. Here, we performed targeted metabolomics and lipidomic analysis which revealed an increase in the de novo biosynthesis of phosphatidylethanolamine (PE) upon p53 activation. Elevated levels of phosphoethanolamine (PEtn), the PE headgroup, in p53 active cells are sustained through PE headgroup recycling, which is partially mediated through the transcriptional activation of autophagy by p53. Disruption of phospholipid headgroup recycling through genetic perturbation of the CDP-ethanolamine pathway results in defects in cell-state specific perturbations in growth and gene expression. Notably, we observe restructuring of endoplasmic reticulum (ER)-mitochondria contacts in cells where headgroup recycling was abrogated, likely an attempt to maintain lipid homeostasis, and this reorganization is reversed when flux through the CDP-Etn pathway is restored. Together, these results suggest that lipid recycling to be an additional tool in the p53 arsenal supporting cellular fitness.

2025-11-17 | GSE268722 | GEO

Glycerol-3-phosphate and Phosphoethanolamine homeostatic switch triggers senescence by rewiring lipid metabolism I

Project description:Cellular senescence impacts many physiological and pathological processes. A durable cell cycle arrest, inflammatory secretory phenotype, and metabolic reprogramming characterize it. Identifying common and specific metabolic liabilities in senescence provide novel inroads to exploit senescence targeting for health benefits. Here, we use dynamic transcriptome and metabolome profiling in different senescence subtypes to reveal common and specific metabolic signatures. Specifically, we pinpoint the homeostatic switch of glycerol-3-phosphate (G3P) and phosphoethanolamine (PEtn) accumulation, intimately linking lipid metabolism to the senescence gene expression program. Mechanistically, p53-dependent glycerol kinase (GK) activation and post-translational inactivation of Phosphate Cytidylyltransferase 2- Ethanolamine (PCYT2) regulate this metabolic switch, which is senogenic. Conversely, G3P phosphatase (G3PP) and Ethanolamine-Phosphate Phospho-Lyase (ETNPPL)-based scavenging of G3P and PEtn is senomorphic. Collectively, our study ties the G3P-PEtn homeostatic switch to controlling lipid droplet biogenesis and phospholipid flux in senescent cells, providing a potential, novel therapeutic avenue for senescence targeting in pathophysiology.

2024-02-01 | GSE248822 | GEO

Glycerol-3-phosphate and Phosphoethanolamine homeostatic switch triggers senescence by rewiring lipid metabolism II

2024-02-01 | GSE248823 | GEO

Media based off the metabolome of tumor interstitial fluid reveals metabolic checkpoints and novel oncometabolites in cancer immunity

Project description:Cancer evades immunity by establishing an immunosuppressive tumor microenvironment (TME). The metabolic composition of the TME represents a ‘checkpoint’ on cancer immunity as the local milieu, the tumor interstitial fluid (TIF), contains metabolites which may render T cells metabolically deficient and alter immune function. We employed media based on a metabolomic profile of TIF (Tumor Interstitial Fluid Medium; TIFM) to define how T cells behave under TME metabolic stress alone. We found that passage of T cells post-stimulation in TIFM, both limited T cell expansion and imprinted lasting effector dysfunction that persisted even after extended expansion in metabolically replete conditions. And we identified phosphoethanolamine (pEtn), a Kennedy pathway intermediate that accumulates in the TME in many cancers, as a driver of T cell dysfunction. Here, bulk RNA-seq was performed on OT-I CD8 T cells activated with peptide and cultured either in RPMI based media or RPMI based media supplemented with pEtn. We identified several key immunologic genes altered by pEtn treatment. However, there was no notable differentiation pattern associated with pEtn treatment as determined through enrichment analysis of T cell differentiation gene sets, suggesting these cells did not necessarily seem to differentiate into canonical exhaustion or anergic states. We further found in other studies that pEtn, as a precursor for the membrane phospholipid phosphatidylethanolamine (PE), drove elevated PE:PC ratios and modulated TCR signaling, in part by depleting T cells of diacylglycerol required for TCR signal transduction, thus contributing to the observed T cell dysfunction.

2025-01-09 | GSE235214 | GEO

the CDP-Etn pathway accelerates mesenchymal-to-epithelial transition in somatic cell reprogramming

Project description:Metabolic reprogramming has emerged as key regulators of cell fate decisions. Whereas the glucose and amino acid metabolism have been extensively documented, the roles of lipid metabolism in pluripotency remain largely unexplored. Here, we report that the CDP-Ethanolamine (CDP-Etn) pathway for phosphatidylethanolamine synthesis is required for somatic cell reprogramming at the early stage. Mechanistically, the CDP-Etn pathway inhibits NF-κB signaling and mesenchymal genes in a Pebp1 dependent manner, resulting in accelerated mesenchymal-to-epithelial transition and enhanced reprogramming. In addition, we show that phospholipids are critical for the growth of mESC though without effects on pluripotency. Our study reveals an unforeseen connection between phospholipids, cell migration and pluripotency and highlights the importance of phospholipids in cell fate transitions.

2019-08-25 | GSE116080 | GEO

A homeostatic switch causing glycerol-3-phosphate and phosphoethanolamine accumulation triggers senescence by rewiring lipid metabolism

Project description:<p>Cellular senescence affects many physiological and pathological processes and is characterized by durable cell cycle arrest, an inflammatory secretory phenotype and metabolic reprogramming. Here, by using dynamic transcriptome and metabolome profiling in human fibroblasts with different subtypes of senescence, we show that a homeostatic switch which results in glycerol-3-phosphate (G3P) and phosphoethanolamine (PEtn) accumulation links lipid metabolism to the senescence gene expression program. Mechanistically, p53-dependent glycerol kinase (GK) activation and post-translational inactivation of Phosphate Cytidylyltransferase 2-Ethanolamine (PCYT2) regulate this metabolic switch, which promotes triglyceride accumulation in lipid droplets and induces the senescence gene expression program. Conversely, G3P phosphatase (G3PP) and Ethanolamine-Phosphate Phospho-Lyase (ETNPPL)-based scavenging of G3P and PEtn acts in a senomorphic way by reducing G3P and PEtn accumulation. Collectively, our study ties G3P and PEtn accumulation to controlling lipid droplet biogenesis and phospholipid flux in senescent cells, providing a potential therapeutic avenue for targeting senescence and related pathophysiology.</p>

2024-01-09 | MTBLS7118 | MetaboLights

Transcriptomic analysis of paired patient isolates of Acinetobacter baumannii following failed colistin treatment

Project description:Colistin is a crucial last-line drug used for the treatment of life-threatening infections caused by multi-drug resistant strains of the Gram-negative bacteria, Acinetobacter baumannii. However, colistin resistant A. baumannii isolates can be isolated following failed colistin therapy. Resistance is most often mediated by the addition of phosphoethanolamine (pEtN) to lipid A by PmrC, following missense mutations in the pmrCAB operon encoding PmrC and the two-component signal transduction system PmrA/PmrB. We recovered an isogenic pair of A. baumannii isolates from a single patient before (6009-1) and after (6009-2) failed colistin treatment that displayed low/intermediate and high levels of colistin resistance, respectively. To understand how increased colistin-resistance arose, we genome sequenced each isolate which revealed that 6009-2 had an extra copy of the insertion sequence element ISAba125 within a gene encoding an H-NS-family transcriptional regulator. Consequently, transcriptomic analysis of the clinical isolates identified was performed and more than 150 genes as differentially expressed in the colistin-resistant, hns mutant, 6009-2. Importantly, the expression of eptA, encoding a second lipid A-specific pEtN transferase, but not pmrC, was significantly increased in the hns mutant. This is the first time an H-NS-family transcriptional regulator has been associated with a pEtN transferase and colistin resistance.

2018-02-19 | GSE107964 | GEO

The effect of ethanolamine phosphate phosphorylase knockout on hepatic gene expression

Project description:Ethanolamine phosphate phospholyase (ETNPPL) is an enzyme that irreversibly degrades phospho-ethanolamine (p-ETN), an intermediate in the Kennedy pathway of phosphatidylethanolamine (PE) biosynthesis. PE is the second most abundant phospholipid in mammalian membranes. Disturbance of hepatic phospholipid homeostasis has been linked to the development of metabolic dysfunction-associated steatotic liver disease (MASLD). We generated whole-body Etnppl knockout mice to investigate the impact of genetic deletion of Etnppl on hepatic lipid metabolism. Female Etnppl+/+ and Etnppl-/- mice were fed either a chow diet for 20 weeks and livers were harvested for lipds, proteins, and gene expression studies.

2024-11-25 | GSE271787 | GEO

PCYT2 inhibits epithelial-to-mesenchymal transition in colorectal cancer by elevating YAP1 phosphorylation

Project description:Metabolic reprogramming is a common feature in tumor progression and metastasis. Like proteins, lipids can transduce signals through lipid-protein interactions. During tumor initiation and metastasis, dysregulation of the Hippo pathway plays a critical role. Specifically, the inhibition of YAP1 phosphorylation leads to the relocation of YAP1 to the nucleus to activate transcription of genes involved in metastasis. Although recent studies reveal the involvement of phosphatidylethanolamine (PE) synthesis enzyme phosphoethanolamine cytidylyltransferase 2 (PCYT2) in tumor chemoresistance, the impact of PCYT2 on tumor metastasis remains elusive. Here, we showed that PCYT2 was significantly downregulated in metastatic colorectal cancer (CRC) and acted as a tumor metastasis suppressor. Mechanistically, PCYT2 increased the interaction between PEBP1 and YAP1-phosphatase PPP2R1A, thus disrupting PPP2R1A-YAP1 association. As a result, phosphorylated-YAP1 levels were increased, leading to YAP1 degradation through the ubiquitin protease pathway. YAP1 reduction in the nucleus repressed the transcription of ZEB1 and Snail2, eventually resulting in metastasis suppression. Our work provides insight into the role of PE synthesis in regulating metastasis and presents PCYT2 as a potential therapeutic target for CRC.

2025-01-01 | GSE278226 | GEO

Selenoprotein I is indispensable for ether lipid homeostasis and proper myelination

Project description:Selenoprotein I (SELENOI) catalyzes the final reaction of the CDP-ethanolamine branch of the Kennedy pathway, generating the phospholipids phosphatidylethanolamine (PE) and plasmenyl-PE. Plasmenyl-PE is a key component of myelin and is characterized by a vinyl ether bond that preferentially reacts with oxidants, thus serves as a sacrificial antioxidant. In humans, multiple loss-of-function mutations in genes affecting plasmenyl-PE metabolism have been implicated in hereditary spastic paraplegia (HSP), including SELENOI. Herein, we developed a mouse model of nervous system-restricted SELENOI deficiency that circumvents embryonic lethality caused by constitutive deletion and recapitulates phenotypic features of HSP. Resulting mice exhibited pronounced alterations in brain lipid composition, which coincided with motor deficits and neuropathology including hypomyelination, elevated reactive gliosis, and microcephaly. Further studies revealed increased lipid peroxidation in oligodendrocyte lineage cells and disrupted oligodendrocyte maturation both in vivo and in vitro. Altogether, these findings detail a critical role for SELENOI-derived plasmenyl-PE in myelination that is of paramount importance for neurodevelopment.

2024-04-03 | MSV000094464 | MassIVE

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data